- Celanese reported an adjusted earnings per share (EPS) of $1.44 for the second quarter, beating the estimate of $1.40, but lower than last year’s $2.38.
- Net sales amounted to $2.53 billion, which is a decline of 4.5% compared to last year but higher than the expected $2.48 billion.
- The Engineered Materials segment had net sales of $1.44 billion, a decrease of 1.7% year-over-year, yet outperforming the estimate of $1.38 billion.
- The Acetyl Chain segment reported net sales of $1.12 billion, down 7.2% from the previous year and slightly below the estimate of $1.13 billion.
- Operating EBITDA stood at $532 million, a 16% drop year-over-year but exceeded the estimate of $513.1 million.
- The company plans to diminish inventory to release cash and anticipates third-quarter adjusted EPS between $1.10 and $1.40.
- Focus on deliberate actions has notably driven earnings, particularly in the Engineered Materials business.
- Celanese expects to generate $700 to $800 million in free cash flow in 2025.
- Analyst recommendations for Celanese stock are comprised of 8 buys, 9 holds, and 2 sells.
“`
Celanese Corp Series A on Smartkarma
Analysts on Smartkarma, like Baptista Research, have been closely following Celanese Corp Series A. According to Baptista Research‘s report titled “Celanese Corporation: High Impact Programs in Engineered Materials As A Vital Tool For Growth!“, the company’s recent earnings report shows a mix of positive signs and ongoing challenges. Celanese has been strategically cutting costs and refining its portfolio to address market conditions, despite facing macroeconomic headwinds.
In another analysis by Baptista Research titled “Celanese’s Strategic Shake-Up: New Board, New Markets, New Era of Dominance?“, the firm’s focus on performance improvement stands out. CEO Scott Richardson and CFO Chuck Kyrish led a proactive approach to boost cash flow, reduce expenses, and make strategic divestments. These moves indicate Celanese’s commitment to reshaping its operations for long-term success in the industry.
A look at Celanese Corp Series A Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 3 | |
| Growth | 2 | |
| Resilience | 2 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 2.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on Smartkarma Smart Scores, Celanese Corp Series A shows a promising long-term outlook. The company scores high in the areas of value and momentum, indicating a strong position in terms of investment value and market performance. Additionally, Celanese Corp Series A demonstrates a moderate score in dividends, suggesting a stable dividend payout.
However, in terms of growth and resilience, Celanese Corp Series A receives lower scores. This indicates that while the company may not be experiencing rapid growth, it still maintains a level of resilience in its operations.
Celanese Corporation, a global chemical and advanced materials producer, operates across North America, Europe, and Asia. With a focus on products such as acetyl, acetate, vinyl emulsion, and engineered polymers, Celanese Corp Series A aims to maintain its position as a key player in the industry and continues to adapt to market trends and demands.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
